Journal article
Association of long COVID with health-related quality-of-life outcomes
Scientific reports, Vol.16(1), p.14229
03/19/2026
DOI: 10.1038/s41598-026-36189-8
PMCID: PMC13139396
PMID: 41857005
Abstract
The association of long COVID with health-related quality-of-life (HrQOL) has not been well-characterized. Participants who received blinded placebo in the ACTIV-2/A5401 outpatient COVID-19 treatment trial were included in an analysis of the association of long COVID with HrQOL (both pre-specified exploratory trial endpoints) 9 months after acute COVID-19. Long COVID was defined as presence of self-assessed COVID-19 symptoms and HrQOL was assessed with EQ-5D-5L and SF-36v2 questionnaires. Associations were evaluated by Fisher's exact tests and Wilcoxon rank-sum tests. Of 546 participants, 13% had long COVID. Long COVID was associated with greater risk of reported problems in the EQ-5D-5L dimensions of mobility, usual activities, pain/discomfort, and anxiety/depression (risk ratios 3.45-6.00, all p < 0.001) and worse self-reported health scores (median 80 vs. 95, p < 0.001). Participants with long COVID also had worse SF-36v2 composite physical and mental component scores (both p < 0.001) and individual SF-36 domain scores (physical functioning, physical role, bodily pain, general health, vitality, social functioning, emotional role, and mental health; all p < 0.001). Associations were similar regardless of baseline (pre-COVID-19) medical history. Long COVID is associated with impaired HrQOL across multiple domains, highlighting the need to develop preventative and therapeutic interventions for this protean condition.
Details
- Title: Subtitle
- Association of long COVID with health-related quality-of-life outcomes
- Creators
- Malini M Gandhi - Brigham and Women's HospitalCarlee Moser - Harvard UniversityJudith S Currier - University of California, Los AngelesJustin Ritz - Harvard UniversityJoseph J Eron - University of North Carolina at Chapel HillEric S Daar - University of California, Los AngelesDavid A Wohl - University of North Carolina at Chapel HillWilliam A. Fischer II - University of North Carolina at Chapel HillUpinder Singh - University of IowaMichael D Hughes - Harvard UniversityDavey M Smith - University of California San DiegoTeresa H Evering - Weill Cornell MedicineKara W Chew - University of California, Los AngelesACTIV-2/A5401 Study Team
- Resource Type
- Journal article
- Publication Details
- Scientific reports, Vol.16(1), p.14229
- DOI
- 10.1038/s41598-026-36189-8
- PMID
- 41857005
- PMCID
- PMC13139396
- NLM abbreviation
- Sci Rep
- ISSN
- 2045-2322
- eISSN
- 2045-2322
- Grant note
- UM1 AI068636 / NIAID NIH HHS UM1 AI069534 / NIAID NIH HHS P30 AI152501 / NIAID NIH HHS UM1 AI069494 / NIAID NIH HHS UM1AI068634 / National Institute of Allergy and Infectious Diseases UM1 AI069424 / NIAID NIH HHS UM1 AI068634 / NIAID NIH HHS UM1 AI069419 / NIAID NIH HHS UM1AI068636 / National Institute of Allergy and Infectious Diseases
- Language
- English
- Date published
- 03/19/2026
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985244657102771
Metrics
1 Record Views